White Pine Capital’s Zimmer Biomet ZBH Stock Holding History

White Pine Capital’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,825	Closed	-$207K	–	230
2025 Q1	$207K	Buy	+1,825	New	+$195K	0.07%	215
2024 Q2	–	Sell	-1,825	Closed	-$220K	–	219
2024 Q1	$220K	Hold	1,825	–	–	0.08%	199
2023 Q4	$222K	Sell	1,825 -300	-14%	-$33.5K	0.09%	200
2023 Q3	$238K	Sell	2,125 -50	-2%	-$6.35K	0.1%	187
2023 Q2	$317K	Sell	2,175 -100	-4%	-$13.6K	0.12%	175
2023 Q1	$294K	Sell	2,275 -50	-2%	-$6.28K	0.11%	164
2022 Q4	$296K	Hold	2,325	–	–	0.12%	164
2022 Q3	$243K	Sell	2,325 -100	-4%	-$11K	0.1%	178
2022 Q2	$255K	Sell	2,425 -100	-4%	-$11.9K	0.1%	179
2022 Q1	$323K	Sell	2,525 -76	-3%	-$9.16K	0.1%	182
2021 Q4	$321K	Hold	2,601	–	–	0.09%	187
2021 Q3	$370K	Hold	2,601	–	–	0.11%	175
2021 Q2	$413K	Buy	2,601 +77	+3%	+$12.5K	0.12%	164
2021 Q1	$392K	Sell	2,524 -77	-3%	-$11.9K	0.12%	169
2020 Q4	$389K	Hold	2,601	–	–	0.14%	160
2020 Q3	$344K	Hold	2,601	–	–	0.14%	156
2020 Q2	$301K	Sell	2,601 -309	-11%	-$35.6K	0.13%	162
2020 Q1	$286K	Sell	2,910 -103	-3%	-$13.5K	0.15%	147
2019 Q4	$438K	Sell	3,013 -309	-9%	-$42.7K	0.17%	137
2019 Q3	$443K	Hold	3,322	–	–	0.17%	154
2019 Q2	$380K	Hold	3,322	–	–	0.14%	161
2019 Q1	$412K	Sell	3,322 -206	-6%	-$23.4K	0.15%	160
2018 Q4	$355K	Hold	3,528	–	–	0.15%	157
2018 Q3	$450K	Hold	3,528	–	–	0.16%	156
2018 Q2	$382K	Sell	3,528 -51	-1%	-$5.55K	0.14%	171
2018 Q1	$379K	Hold	3,579	–	–	0.14%	166
2017 Q4	$419K	Hold	3,579	–	–	0.15%	156
2017 Q3	$407	Hold	3,579	–	–	﹤0.01%	156
2017 Q2	$446K	Hold	3,579	–	–	0.18%	151
2017 Q1	$424K	Hold	3,579	–	–	0.17%	149
2016 Q4	$359K	Hold	3,579	–	–	0.15%	155
2016 Q3	$452K	Hold	3,579	–	–	0.19%	143
2016 Q2	$418K	Hold	3,579	–	–	0.18%	159
2016 Q1	$371K	Hold	3,579	–	–	0.16%	162
2015 Q4	$357K	Hold	3,579	–	–	0.16%	167
2015 Q3	$326K	Sell	3,579 -103	-3%	-$10.3K	0.15%	170
2015 Q2	$390K	Hold	3,682	–	–	0.17%	159
2015 Q1	$420K	Hold	3,682	–	–	0.17%	159
2014 Q4	$405K	Sell	3,682 -206	-5%	-$21.7K	0.14%	163
2014 Q3	$380K	Sell	3,888 -52	-1%	-$5.12K	0.13%	170
2014 Q2	$397K	Sell	3,940 -206	-5%	-$20.1K	0.14%	160
2014 Q1	$381K	Hold	4,146	–	–	0.13%	171
2013 Q4	$375K	Hold	4,146	–	–	0.13%	163
2013 Q3	$331K	Hold	4,146	–	–	0.11%	177
2013 Q2	$302K	Buy	+4,146	New	+$310K	0.1%	180

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

White Pine Capital's ZBH Position: Q2 2025 in Review

White Pine Capital sold out of Zimmer Biomet (ZBH) in Q2 2025, closing a stake of 1,825 shares — an estimated $207K sold.

White Pine Capital first reported a position in ZBH in Q2 2013 and held it in 45 quarters. The position peaked at $452K in Q3 2016. 934 funds tracked by Wall St. Rank hold ZBH as of Q2 2025.

White Pine Capital reported no remaining Zimmer Biomet position as of Q2 2025 after selling out during the quarter.
White Pine Capital sold 1,825 Zimmer Biomet shares in Q2 2025, an estimated $207K.
White Pine Capital first reported a position in Zimmer Biomet in Q2 2013 and held it in 45 quarters.
White Pine Capital's Zimmer Biomet position peaked at $452K in Q3 2016.
934 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2025.

Based on White Pine Capital's 13F filing for Q2 2025, filed 12 Aug 2025.